publication . Article . 2014

association between clinical measures and florbetapir f18 pet neuroimaging in mild or moderate alzheimer s disease dementia

Michael M. Witte; Paula Trzepacz; Michael Case; Peng Yu; Helen Hochstetler; Mitchell Quinlivan; Karen Sundell; David Henley;
Restricted
  • Published: 11 Mar 2014 Journal: The Journal of Neuropsychiatry and Clinical Neurosciences, volume 26, pages 214-220 (issn: 0895-0172, eissn: 1545-7222, Copyright policy)
  • Publisher: American Psychiatric Association Publishing
Abstract
The authors conducted a retrospective, cross-sectional analysis comparing baseline neuropsychiatric and other clinical characteristics in 199 expert-diagnosed mild and moderate Alzheimer’s dementia patients participating in industry-sponsored clinical trials of an investigational therapy, where 18% lacked florbetapir positron emission tomography (PET) evidence of Alzheimer’s neuropathology.
Subjects
free text keywords: Psychiatry and Mental health, Clinical Neurology, Neuroimaging, Psychology, Positron emission tomography, medicine.diagnostic_test, medicine, Disease, Psychiatry, medicine.medical_specialty, Neuropathology, Investigational therapy, Dementia, medicine.disease, Clinical trial, Florbetapir F18
Powered by OpenAIRE Research Graph
Any information missing or wrong?Report an Issue